Low expression of MUC2 is associated with longer disease-free survival in patients with colorectal carcinoma

Conclusion: MUC2 immunostaining may have distinct clinical significance and provide valuable information and could be considered as an important independent prognostic factor while planning the adjuvant therapy in CRC. In future perspective, characterization of MUC2 immunostaining on a large number of cases and molecular studies may be needed.

Source: The Saudi Journal of Gastroenterology - January 28, 2019 Category: Gastroenterology Authors: Jaudah Al-Maghrabi Shabnum Sultana Wafaey Gomaa Source Type: research